High-dose vitamin E supplements are linked to a modest but real increase in prostate cancer risk. The largest trial ever conducted on this question found that men taking 400 IU of vitamin E daily developed 17% more prostate cancers than men taking a placebo. That translates to about 11 extra cases per 1,000 men over seven years. The risk isn’t enormous, but it’s consistent enough that major health organizations now recommend against taking vitamin E supplements for cancer prevention.
What the SELECT Trial Found
The Selenium and Vitamin E Cancer Prevention Trial, known as SELECT, is the definitive study on this topic. It enrolled more than 35,000 men and randomly assigned them to take vitamin E, selenium, both, or a placebo. The vitamin E dose was 400 IU per day of synthetic alpha-tocopherol, which is about 12 times the recommended daily intake of 15 mg for adults.
After an average of seven years (5.5 years taking the supplements, followed by 1.5 years of monitoring after they stopped), the results were clear. Among men taking only placebos, 65 out of every 1,000 were diagnosed with prostate cancer. Among men taking vitamin E alone, that number rose to 76 out of every 1,000. The 17% increase was statistically significant, meaning it was unlikely to be due to chance. Notably, the increased risk persisted even after men stopped taking the supplements, suggesting that the biological effects of long-term high-dose supplementation don’t simply switch off.
Selenium did not reduce the risk either, and taking both selenium and vitamin E together did not produce the same increase seen with vitamin E alone.
Why an Earlier Study Showed the Opposite
Part of what makes this topic confusing is that an earlier, well-known trial suggested vitamin E was protective. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC), conducted in Finnish male smokers, found that a much lower dose of vitamin E (50 mg daily, roughly equivalent to 50 IU) reduced prostate cancer incidence by 32% and advanced prostate cancer by 40% over five to eight years of supplementation.
The critical difference is dose. The ATBC study used a dose close to the recommended daily amount, while SELECT used a dose roughly eight times higher. This pattern, where a nutrient is beneficial at normal levels but harmful at megadoses, is common in nutrition science. It’s one reason the SELECT results caught researchers off guard: they expected to confirm the earlier benefit, not find the opposite.
The Role of Different Vitamin E Forms
Vitamin E isn’t a single molecule. It’s a family of compounds, and the two most relevant forms are alpha-tocopherol and gamma-tocopherol. Most supplements, including the one used in SELECT, contain only alpha-tocopherol. This matters because taking large doses of alpha-tocopherol actually lowers blood levels of gamma-tocopherol, disrupting the natural balance between the two.
In lab studies, both forms inhibit the growth of human prostate cancer cells, but gamma-tocopherol is more potent. A large case-control study of over 10,000 men found that higher blood levels of both forms were associated with lower prostate cancer risk, with gamma-tocopherol showing the stronger protective effect. So flooding the body with one form while suppressing the other may strip away a natural defense. This is one plausible explanation for why high-dose alpha-tocopherol supplements increased risk even though vitamin E from food (which contains a mix of forms) appears neutral or slightly protective.
How High-Dose Vitamin E May Promote Cancer
Vitamin E has long been celebrated as an antioxidant, which is why so many people assumed it would prevent cancer. But at high concentrations in prostate tissue, it appears to do the opposite. Laboratory and animal research has identified several ways this can happen.
High-dose vitamin E ramps up the activity of enzymes in prostate cells that activate environmental carcinogens, particularly compounds found in grilled meats, tobacco smoke, and air pollution. When these enzymes become overactive, they generate large amounts of free radicals, the very molecules antioxidants are supposed to neutralize. In cell studies, vitamin E-treated prostate cells showed significantly higher levels of these reactive molecules compared to untreated cells, along with markers of inflammation and DNA damage. The effect was dose-dependent: higher concentrations of vitamin E produced more pronounced changes, while very low doses had little or no effect.
In animal models, these same enzyme changes were confirmed in living prostate tissue, along with signs of oxidative damage to fats and proteins in the cells. Researchers also demonstrated that vitamin E-treated cells exposed to a common environmental carcinogen underwent malignant transformation at higher rates than untreated cells. In short, high-dose vitamin E appears to prime prostate cells to be more vulnerable to the carcinogens they encounter in daily life.
What This Means for Supplements
The U.S. Preventive Services Task Force recommends against taking vitamin E supplements for the purpose of preventing cancer or cardiovascular disease. The American Cancer Society notes that men in the SELECT trial who took vitamin E had a slightly higher risk of prostate cancer and states that no supplement has been found helpful enough for experts to recommend it for prostate cancer prevention.
These recommendations apply specifically to supplements, not to vitamin E from food. The amounts you get from a normal diet (nuts, seeds, vegetable oils, leafy greens) are far below the levels that caused problems in SELECT. A handful of almonds contains about 7 mg of vitamin E, roughly half the daily recommended amount and a fraction of the 180 mg used in the trial. Food sources also provide a natural mix of vitamin E forms, rather than a concentrated dose of one.
If you’re currently taking a vitamin E supplement at doses well above the 15 mg daily recommendation, the evidence suggests this is not protecting your prostate and may be doing the opposite. Men who took high-dose vitamin E in SELECT continued to show elevated prostate cancer rates even 1.5 years after stopping the supplements, which underscores that the effects are not immediately reversible. The clearest takeaway from two decades of research is that more is not better when it comes to vitamin E and prostate health.